OptimizeRx Corp (OPRX) Free cash flow 2016–2025
OptimizeRx Corp (OPRX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$18.7MFY2025 · since FY2016: -$644,399 → $18.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $18.7M | +290.6% |
| FY2024 | $4.8M | +165.2% |
| FY2023 | -$7.3M | -169.3% |
| FY2022 | $10.6M | +1589.8% |
| FY2021 | $625,717 | +109.8% |
| FY2020 | -$6.4M | -264.8% |
| FY2019 | -$1.7M | -330.6% |
| FY2018 | $758,193 | +149.8% |
| FY2017 | -$1.5M | -136.2% |
| FY2016 | -$644,399 | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice